This study is testing a device called Sylfirm X radiofrequency microneedling to see how well and how safely it treats melasma (a skin condition causing dark patches). Researchers want to see if the Sylfirm X device can improve skin quality, tone, and pigment. They will measure success by how accurately a blinded investigator can identify post-treatment photos compared to baseline photos after 28 days. You may be able to join if you are a healthy woman between 18 and 70 years old, have melasma, and are willing to have the treatment and follow the study schedule. This study plans to enroll 90 participants, but its current recruitment status is unclear.

Study design

This interventional study plans to enroll 90 healthy women. It is designed to evaluate the efficacy and safety of the Sylfirm X device.

What's involved

You would receive RF microneedling treatment and need to follow a schedule for treatments, follow-up appointments, and post-treatment instructions.

Compensation

Not stated in the trial record.

Follow-up

The primary endpoint is measured at 28 days after treatment.

AI-generated from the public study record. Only the study team can confirm whether you're eligible — confirm details with them before making decisions.